Trial intelligence / Profile preview

Effect of Terminalia chebula in treatment of melasma

IRCT20110310006026N10Phase 2Completed

Sponsor
Kerman University of Medical Sciences
Start
Sep 2019
Countries
1
01

Overview

Phase 2 trial of terminalia chebula in melasma, sponsored by Kerman University of Medical Sciences. Started Sep 2019; status: completed.

02

Drugs

terminalia chebula
03

Conditions

melasma

Beyond the preview

Go deeper on IRCT20110310006026N10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20110310006026N10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call